KromaTiD, Inc. is a CSU startup company that provides products and services for mutation detection and disease diagnosis. KromaTiD’s patented dGH™ chromosome imaging platform enables detection of all types of chromosomal rearrangements including previously undetectable cryptic inversions. Launched in 2013, KromaTiD’s research products and services are paving the way to a deeper understanding of genetic diseases, including cancers and developmental disorders.
Kromatid provides genetic researchers with proprietary tools to discover and detect otherwise invisible chromosomal rearrangements. This unique data provides disease researchers and pharmaceutical developers with important insights into the genetic causes of cancers, developmental disorders and other diseases.
An array of gene editing, oncology and genetic disease products as well as chromatid paints and custom assays and services.
For more information visit www.kromatid.com